Navigate this market better. Subscribe for FREE stock alerts and information.

Friday, April 25, 2014

Prestige Brands to purchase Insight Pharmaceuticals for $750 mln, (NYSE: PBH)

Prestige Brands Holdings Inc, a marketer and distributor of healthcare and cleaning products, said it would purchase rival Insight Pharmaceuticals Corp for $750 million in cash to expand its feminine care products range. As part of the deal, Prestige will acquire tax attributes with a present value of about $100 million, the company said in a statement.

Prestige Brands Holdings, Inc. (Prestige) is a holding company. Shares of PBH fell by 0.91% or $-0.25/share to $27.31. In the past year, the shares have traded as low as $24.94 and as high as $36.69. On average, 410363 shares of PBH exchange hands on a given day and today's volume is recorded at 383228.



Source